Screening and identification of heparanase RNAi sequence

熊震; 汤旭东; 房殿春; 陈婷; 余松涛; 陈陵; 罗元辉; 杨仕明

您当前的位置：

首页 >

文章列表页 >

Screening and identification of heparanase RNAi sequence

更新时间：2026-01-09

- Screening and identification of heparanase RNAi sequence
- Journal of Army Medical University Vol. 29, Issue 20, Pages: 1929-1932(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： Q556.2;Q785;R735.7
- Published：2007
- 稿件说明：
移动端阅览
熊震,汤旭东,房殿春,陈婷,余松涛,陈陵,罗元辉,杨仕明.人肝素酶RNAi序列的筛选及鉴定[J].陆军军医大学学报(原第三军医大学学报),2007,29(20):1929-1932.

　XIONG Zhen,TANG Xu-dong,FANG Dian-chun,CHEN Ting,YU Song-tao,CHEN Ling,LUO Yuan-hui,YANG Shi-ming.Screening and identification of heparanase RNAi sequence[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(20):1929-1932.
熊震,汤旭东,房殿春,陈婷,余松涛,陈陵,罗元辉,杨仕明.人肝素酶RNAi序列的筛选及鉴定[J].陆军军医大学学报(原第三军医大学学报),2007,29(20):1929-1932. DOI：

　XIONG Zhen,TANG Xu-dong,FANG Dian-chun,CHEN Ting,YU Song-tao,CHEN Ling,LUO Yuan-hui,YANG Shi-ming.Screening and identification of heparanase RNAi sequence[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(20):1929-1932. DOI：

摘要

目的筛选及鉴定有效人肝素酶（heparanase

Hpa）RNA干扰（RNA interference）序列。方法通过在线网络软件选择3个Hpa RNAi的靶点，再设计1组无关序列作阴性对照。通过基因重组技术，把3个干扰片段及阴性对照片段分别克隆入质粒pGenesile-1，脂质体法稳定转染至HepG2肝癌细胞；经G418抗性筛选后各挑选2个阳性克隆进行扩大培养；Western blot检测不同克隆肝素酶蛋白的表达水平，并进一步采用RT-PCR验证筛选克隆肝素酶mRNA的表达水平。结果通过在线网络软件设计3个RNA干扰序列，分别为Hpa/RNAi-1：GGCTATCTCTTCTGTTCAA，Hpa/RNAi-2：TCCTGTCCGTCACCATTGA，Hpa/RNAi-3:CTCAGTTGCTCCTGGACTA及阴性对照序列Hpa/RNAi-N : CTACCGTTGTATAGGTGT；测序证实克隆入pGenesil-1载体的3个干扰序列及阴性对照序列与设计序列完全一致；经G418抗性筛选后形成的阳性克隆采用Western blot检测其肝素酶蛋白的表达，结果表明3个干扰序列对HepG2细胞人肝素酶蛋白的表达均有抑制作用，其中Hpa/RNAi-1和Hpa/RNAi-3干扰链的抑制效果最好，分别达到57%和71%；RT-PCR检测结果亦表明Hpa/RNAi-1和Hpa/RNAi-3序列在mRNA水平对肝素酶有较好的抑制效果。结论成功筛选出有效的人肝素酶RANi序列。

Abstract

Objective To screen and identify the efficient heparanase (Hpa) RNAi sequence. Methods We chose three candidate targets of Hpa RNAi through online software and designed a set of independent sequence as negative control group. The three interference fragments and independent sequence were cloned into pGenesile-1 expression vector by gene recombination technique. The recombinant vectors were then transfected into HepG2 liver cancer cell line. After screening by G418

the expression of heparanase in the selected clones was detected by Western blot

and its mRNA expression level by RT-PCR. Results The three interference sequences designed with online tool respectively was Hpa/RNAi-1: GGCTATCTCTTCTGTTCAA; Hpa/RNAi-2: TCCTGTCCGTCACCATTGA; Hpa/RNAi-3: CTCAGTTGCTCCTGGACTA and negative control Hpa/RNAi-N:CTACCGTTGTATAGGTGT; The three interference sequence were cloned into pGenesil-1 vector

respectively. Sequencing analysis confirmed their correctness. Positive clones formed after their stable transfection into HepG2 and G418 screening. Compared with untransfected HepG2 and negative control

Western blot analysis showed heparanase protein in interference sequence transfected HepG2 was significantly down-regulated. Hpa/RNAi-1 and Hpa/RNAi-3 showed better inhibition effect

with their inhibition efficiency to 57% and 71% respectively; RT-PCR result proved the sequence of Hpa/RNAi-1 and Hpa/RNAi-3 could effectively down-regulate heparanase on mRNA level. Conclusion We successfully screen and identify the efficient heparanase RNAi sequence.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

ETS1 transcription up-regulates FBXO45 and promotes invasion and migration of hepatocellular carcinoma via epithelial-mesenchymal transition

Bilirubin impairs the sorafenib sensitivity in Huh7 cells through fatty acid oxidation by up-regulating PPARα/CPT1A

HBx promotes liver tumor in mice by inhibiting microRNA-145a-5p

Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells

Hepatitis B virus X promotes tumorigenesis of hepatocellular carcinoma through HIPPO signaling pathway in mice

Related Author

ZHU Zhenbao

WU Feifan

GU Yongpeng

XIE Chuanming

ZHANG Leida

Jun TAN

Chi ZHANG

Yan DONG

Related Institution

Department of Hepatobiliary Surgery， the Second Affiliated Hospital of Chongqing Medical University

Department of Hepatobiliary Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Oncology, First Affiliated Hospital, Army Medical University (Third Military Medical University)

Molecular Medicine and Cancer Research Center, Biochemistry and Molecular Biology Research Center, College of Pharmacy, Chongqing Medical University

Department of Neurosurgery, the Second Affiliated Hospital of Chongqing Medical University

⁰